112 related articles for article (PubMed ID: 3894715)
1. [High-dose cytosine arabinoside in acute leukemia: a cooperative study].
Urabe A; Takaku F; Mizoguchi H; Yamada O; Wakabayashi Y; Miura Y; Sakamoto S; Yoshida M; Miwa S; Asano S
Rinsho Ketsueki; 1985 Feb; 26(2):184-8. PubMed ID: 3894715
[No Abstract] [Full Text] [Related]
2. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
Masi M; Vivarelli F; Paolucci P; Vecchi V
Minerva Pediatr; 1975 Sep; 27(28):1539-50. PubMed ID: 1101022
[No Abstract] [Full Text] [Related]
3. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
[No Abstract] [Full Text] [Related]
4. [High-dose cytosine arabinoside therapy in refractory acute leukemia].
Yorimitsu S; Takahashi I; Kitazima K; Kimura I; Hara M; Tokuda M
Rinsho Ketsueki; 1984 Dec; 25(12):1941-6. PubMed ID: 6533329
[No Abstract] [Full Text] [Related]
5. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
[No Abstract] [Full Text] [Related]
6. [Cytosine-arabinoside in the treatment of acute leukemias].
Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
[No Abstract] [Full Text] [Related]
7. [Value of high-dose cytosine-arabinoside in the treatment of resistant acute leukemia].
Witz F; Olive D; Lederlin P; Bordigoni P; Troussard X; Grosbois B; Schaison G; Cornu G
Presse Med; 1987 Feb; 16(4):159-62. PubMed ID: 2950446
[TBL] [Abstract][Full Text] [Related]
8. [Low-dose cytosine arabinoside therapy in relapsed acute leukemia: correlation of clinical response and in vitro sensitivity tests].
Ninomiya T; Hirose M; Takaue Y; Watanabe T; Ouchi T; Sato J; Koyama T; Abe T; Suzue T
Rinsho Ketsueki; 1987 Oct; 28(10):1763-70. PubMed ID: 3452642
[No Abstract] [Full Text] [Related]
9. [The effect of cytosine arabinoside on cell kinetics in adult acute leukemia and its correlation to the therapeutic response].
Furusawa S; Adachi Y; Nomura T; Komiya M
Rinsho Ketsueki; 1972 Dec; 13(6):943-50. PubMed ID: 4675065
[No Abstract] [Full Text] [Related]
10. High-dose cytosine arabinoside in the treatment of resistant acute leukemia.
Takaku F; Urabe A; Mizoguchi H; Yamada O; Wakabayashi Y; Miura Y; Sakamoto S; Yoshida M; Miwa S; Asano S
Semin Oncol; 1985 Jun; 12(2 Suppl 3):144-9. PubMed ID: 3859929
[No Abstract] [Full Text] [Related]
11. [Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, 6-mercaptopurine riboside and prednisolone].
Hirano M; Morita A; Sako F; Uetani T; Koie K
Rinsho Ketsueki; 1972 Dec; 13(6):951-7. PubMed ID: 4675066
[No Abstract] [Full Text] [Related]
12. [Combination chemotherapy with cytosine arabinoside and daunomycin in childhood acute leukemia].
Tsukimoto I; Mimaya J; Toyosaka H; Nagao T; Hanawa Y
Rinsho Ketsueki; 1973 May; 14(5):596-603. PubMed ID: 4738276
[No Abstract] [Full Text] [Related]
13. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
[No Abstract] [Full Text] [Related]
14. [High-dose cytosine arabinoside administration in the treatment of refractory leukemia].
Yoshida M; Furukawa Y; Akashi M; Komatsu N; Takeda K; Muroi K; Ikeda K; Ohsaka A; Ohta M; Suda K
Rinsho Ketsueki; 1985 Aug; 26(8):1258-64. PubMed ID: 3865002
[No Abstract] [Full Text] [Related]
15. Treatment of refractory acute leukemia with high-dose cytosine arabinoside.
Liu MC; Chen YC; Tsay W; Shen MC; Wang CH; Liu CH
Taiwan Yi Xue Hui Za Zhi; 1987 Jun; 86(6):628-33. PubMed ID: 3655707
[No Abstract] [Full Text] [Related]
16. [High dose cytosine arabinoside (HDCA) in children with refractory leukemia or malignant lymphoma (3 g/m2 vs 1.5 g/m2)].
Yumura K; Kawa K; Ishihara S; Hara J; Doi S; Tomita K; Yabuuchi H
Rinsho Ketsueki; 1985 Dec; 26(12):1979-85. PubMed ID: 3834163
[No Abstract] [Full Text] [Related]
17. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Malpas J; Mathé G; Hayat M
Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
[No Abstract] [Full Text] [Related]
18. [Combined chemotherapy: prednisone, cytosine arabinose and vincristine in the treatment of acute non-lymphoblastic leukemia in the adult].
Avilés-Miranda A; Monroy-Arellano LM; Conte-Lanza G; Morales-Polanco MR; Pizzuto-Chávez J
Gac Med Mex; 1980 Aug; 116(8):359-64. PubMed ID: 7002697
[No Abstract] [Full Text] [Related]
19. [Results of cytosine arabinoside treatment in adult patients with acute myeloblastic leukemia].
Gepner-Woźniewska M; Retmańska A; Sobczynska-Czechowska Z; Pawelski S
Acta Haematol Pol; 1973; 4(1):1-9. PubMed ID: 4522083
[No Abstract] [Full Text] [Related]
20. [Method of administration and inactivation of cytosine arabinoside in acute leukemia].
Hirschmann WD; Kovacs EL; Gerecke D; Kaulen HD; Voigtmann R; Gross R
Verh Dtsch Ges Inn Med; 1975; 81():1114-6. PubMed ID: 1229411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
